Quantitation of HBV covalently closed circular DNA in micro formalin fixed paraffin-embedded liver tissue using rolling circle amplification in combination with real-time PCR (Q54360400)

From Wikidata

Jump to navigation Jump to search

scientific article published on June 30, 2011

Language	Label	Description	Also known as
English	Quantitation of HBV covalently closed circular DNA in micro formalin fixed paraffin-embedded liver tissue using rolling circle amplification in combination with real-time PCR	scientific article published on June 30, 2011

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21741960

Quantitation of HBV covalently closed circular DNA in micro formalin fixed paraffin-embedded liver tissue using rolling circle amplification in combination with real-time PCR (English)

1 reference

10.1016/J.CCA.2011.06.031

https://api.crossref.org/works/10.1016/J.CCA.2011.06.031

6 December 2024

author name string

Yanwei Zhong

1

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21741960

Jiaqi Han

2

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21741960

Zhengsheng Zou

3

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21741960

Shuhong Liu

4

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21741960

Bo Tang

5

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21741960

Xiaoqiang Ren

6

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21741960

Xiaodong Li

7

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21741960

Yulai Zhao

8

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21741960

Yan Liu

9

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21741960

Dongqing Zhou

10

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21741960

Weijie Li

11

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21741960

Jingmin Zhao

12

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21741960

Dongping Xu

13

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21741960

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21741960

6 December 2024

publication date

30 June 2011

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21741960

full work available at URL

https://api.elsevier.com/content/article/PII:S0009898111003652?httpAccept=text/xml

1 reference

10.1016/J.CCA.2011.06.031

https://api.crossref.org/works/10.1016/J.CCA.2011.06.031

6 December 2024

https://api.elsevier.com/content/article/PII:S0009898111003652?httpAccept=text/plain

1 reference

10.1016/J.CCA.2011.06.031

https://api.crossref.org/works/10.1016/J.CCA.2011.06.031

6 December 2024

Clinica Chimica Acta

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21741960

412

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21741960

21-22

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21741960

1905-1911

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21741960

EASL Clinical Practice Guidelines: management of chronic hepatitis B.

1

1 reference

10.1016/J.CCA.2011.06.031

https://api.crossref.org/works/10.1016/J.CCA.2011.06.031

6 December 2024

Therapeutic strategies in the management of patients with chronic hepatitis B virus infection.

3

1 reference

10.1016/J.CCA.2011.06.031

https://api.crossref.org/works/10.1016/J.CCA.2011.06.031

6 December 2024

New insight on hepatitis B virus persistence from the study of intrahepatic viral cccDNA.

4

1 reference

10.1016/J.CCA.2011.06.031

https://api.crossref.org/works/10.1016/J.CCA.2011.06.031

6 December 2024

Intrahepatic levels and replicative activity of covalently closed circular hepatitis B virus DNA in chronically infected patients

5

1 reference

10.1016/J.CCA.2011.06.031

https://api.crossref.org/works/10.1016/J.CCA.2011.06.031

6 December 2024

Control of cccDNA function in hepatitis B virus infection.

6

1 reference

10.1016/J.CCA.2011.06.031

https://api.crossref.org/works/10.1016/J.CCA.2011.06.031

6 December 2024

Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy.

7

1 reference

10.1016/J.CCA.2011.06.031

https://api.crossref.org/works/10.1016/J.CCA.2011.06.031

6 December 2024

Intrahepatic hepatitis B virus covalently closed circular DNA can be a predictor of sustained response to therapy

8

1 reference

10.1016/J.CCA.2011.06.031

https://api.crossref.org/works/10.1016/J.CCA.2011.06.031

6 December 2024

Quantitative analysis of HBV cccDNA from clinical specimens: correlation with clinical and virological response during antiviral therapy

9

1 reference

10.1016/J.CCA.2011.06.031

https://api.crossref.org/works/10.1016/J.CCA.2011.06.031

6 December 2024

Virologic monitoring of hepatitis B virus therapy in clinical trials and practice: recommendations for a standardized approach

10

1 reference

10.1016/J.CCA.2011.06.031

https://api.crossref.org/works/10.1016/J.CCA.2011.06.031

6 December 2024

Total and covalently closed circular DNA detection in liver tissue of long-term survivors transplanted for HBV-related cirrhosis

12

1 reference

10.1016/J.CCA.2011.06.031

https://api.crossref.org/works/10.1016/J.CCA.2011.06.031

6 December 2024

Intracellular levels of hepatitis B virus DNA and pregenomic RNA in peripheral blood mononuclear cells of chronically infected patients

13

1 reference

10.1016/J.CCA.2011.06.031

https://api.crossref.org/works/10.1016/J.CCA.2011.06.031

6 December 2024

Real-time PCR quantitation of hepatitis B virus total DNA and covalently closed circular DNA in peripheral blood mononuclear cells from hepatitis B virus-infected patients

14

1 reference

10.1016/J.CCA.2011.06.031

https://api.crossref.org/works/10.1016/J.CCA.2011.06.031

6 December 2024

A quantitative competitive PCR assay for the covalently closed circular form of the duck hepatitis B virus

16

1 reference

10.1016/J.CCA.2011.06.031

https://api.crossref.org/works/10.1016/J.CCA.2011.06.031

6 December 2024

A new and sensitive method for the quantification of HBV cccDNA by real-time PCR.

17

1 reference

10.1016/J.CCA.2011.06.031

https://api.crossref.org/works/10.1016/J.CCA.2011.06.031

6 December 2024

A quantitative method to detect HBV cccDNA by chimeric primer and real-time polymerase chain reaction.

18

1 reference

10.1016/J.CCA.2011.06.031

https://api.crossref.org/works/10.1016/J.CCA.2011.06.031

6 December 2024

Quantitation of covalently closed circular hepatitis B virus DNA in chronic hepatitis B patients.

19

1 reference

10.1016/J.CCA.2011.06.031

https://api.crossref.org/works/10.1016/J.CCA.2011.06.031

6 December 2024

Quantitation of hepatitis B virus (HBV) covalently closed circular DNA (cccDNA) in the liver of HBV-infected patients by LightCycler real-time PCR.

21

1 reference

10.1016/J.CCA.2011.06.031

https://api.crossref.org/works/10.1016/J.CCA.2011.06.031

6 December 2024

Validation of a sensitive and specific real-time PCR for detection and quantitation of hepatitis B virus covalently closed circular DNA in plasma of chronic hepatitis B patients

22

1 reference

10.1016/J.CCA.2011.06.031

https://api.crossref.org/works/10.1016/J.CCA.2011.06.031

6 December 2024

Detection of hepatitis B virus covalently closed circular DNA in paraffin-embedded and cryo-preserved liver biopsies of chronic hepatitis B patients

23

1 reference

10.1016/J.CCA.2011.06.031

https://api.crossref.org/works/10.1016/J.CCA.2011.06.031

6 December 2024

Enhanced specificity of real-time PCR for measurement of hepatitis B virus cccDNA using restriction endonuclease and plasmid-safe ATP-dependent DNase and selective primers

24

1 reference

10.1016/J.CCA.2011.06.031

https://api.crossref.org/works/10.1016/J.CCA.2011.06.031

6 December 2024

Circulating and liver resident CD4 CD25 regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B

26

1 reference

10.1016/J.CCA.2011.06.031

https://api.crossref.org/works/10.1016/J.CCA.2011.06.031

6 December 2024

Features and clinical implications of hepatitis B virus genotypes and mutations in basal core promoter/precore region in 507 Chinese patients with acute and chronic hepatitis B.

27

1 reference

10.1016/J.CCA.2011.06.031

https://api.crossref.org/works/10.1016/J.CCA.2011.06.031

6 December 2024

Hepatitis B virus (HBV) subgenotypes C2 and B2 differ in lamivudine- and adefovir-resistance-associated mutational patterns in HBV-infected Chinese patients

28

1 reference

10.1016/J.CCA.2011.06.031

https://api.crossref.org/works/10.1016/J.CCA.2011.06.031

6 December 2024

Genotypic resistance profile of hepatitis B virus (HBV) in a large cohort of nucleos(t)ide analogue-experienced Chinese patients with chronic HBV infection.

29

1 reference

10.1016/J.CCA.2011.06.031

https://api.crossref.org/works/10.1016/J.CCA.2011.06.031

6 December 2024

Variable influence of mutational patterns in reverse-transcriptase domain on replication capacity of hepatitis B virus isolates from antiviral-experienced patients

30

1 reference

10.1016/J.CCA.2011.06.031

https://api.crossref.org/works/10.1016/J.CCA.2011.06.031

6 December 2024

Sensitive and accurate quantitation of hepatitis B virus DNA using a kinetic fluorescence detection system (TaqMan PCR).

31

1 reference

10.1016/J.CCA.2011.06.031

https://api.crossref.org/works/10.1016/J.CCA.2011.06.031

6 December 2024

Quantification of hepatitis B virus covalently closed circular DNA in patients with hepatocellular carcinoma

32

1 reference

10.1016/J.CCA.2011.06.031

https://api.crossref.org/works/10.1016/J.CCA.2011.06.031

6 December 2024

The genetic organization of integrated hepatitis B virus DNA in the human hepatoma cell line PLC/PRF/5.

33

1 reference

10.1016/J.CCA.2011.06.031

https://api.crossref.org/works/10.1016/J.CCA.2011.06.031

6 December 2024

HBV cccDNA in patients' sera as an indicator for HBV reactivation and an early signal of liver damage

34

1 reference

10.1016/J.CCA.2011.06.031

https://api.crossref.org/works/10.1016/J.CCA.2011.06.031

6 December 2024

Effect of lamivudine therapy on the serum covalently closed-circular (ccc) DNA of chronic hepatitis B infection

35

1 reference

10.1016/J.CCA.2011.06.031

https://api.crossref.org/works/10.1016/J.CCA.2011.06.031

6 December 2024

Quantitative detection of hepatitis B virus covalently closed circular DNA in sera of chronic hepatitis B patients with a newly established assay

36

1 reference

10.1016/J.CCA.2011.06.031

https://api.crossref.org/works/10.1016/J.CCA.2011.06.031

6 December 2024

Rolling-circle amplification of viral DNA genomes using phi29 polymerase

37

1 reference

10.1016/J.CCA.2011.06.031

https://api.crossref.org/works/10.1016/J.CCA.2011.06.031

6 December 2024

A sequence-independent strategy for detection and cloning of circular DNA virus genomes by using multiply primed rolling-circle amplification

38

1 reference

10.1016/J.CCA.2011.06.031

https://api.crossref.org/works/10.1016/J.CCA.2011.06.031

6 December 2024

A simple method for cloning the complete begomovirus genome using the bacteriophage phi29 DNA polymerase.

39

1 reference

10.1016/J.CCA.2011.06.031

https://api.crossref.org/works/10.1016/J.CCA.2011.06.031

6 December 2024

Rolling circle amplification, a powerful tool for genetic and functional studies of complete hepatitis B virus genomes from low-level infections and for directly probing covalently closed circular DNA.

40

1 reference

10.1016/J.CCA.2011.06.031

https://api.crossref.org/works/10.1016/J.CCA.2011.06.031

6 December 2024

Comparative analysis of drug resistant mutations in the reverse transcriptase domain of hepatitis B virus covalently closed circular DNA and the viral relax circle DNA

41

1 reference

10.1016/J.CCA.2011.06.031

https://api.crossref.org/works/10.1016/J.CCA.2011.06.031

6 December 2024

Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers

42

1 reference

10.1016/J.CCA.2011.06.031

https://api.crossref.org/works/10.1016/J.CCA.2011.06.031

6 December 2024

Serum hepatitis B surface antigen quantitation can reflect hepatitis B virus in the liver and predict treatment response.

43

1 reference

10.1016/J.CCA.2011.06.031

https://api.crossref.org/works/10.1016/J.CCA.2011.06.031

6 December 2024

Identifiers

10.1016/J.CCA.2011.06.031

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21741960

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 May 2018

http://europepmc.org/abstract/MED/21741960

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54360400&oldid=2284171650"